No abstract available
Keywords:
HNSCC; PD-L1; PD1; artificial intelligence; biomarkers.
MeSH terms
-
Animals
-
Antineoplastic Agents, Immunological / therapeutic use*
-
B7-H1 Antigen / antagonists & inhibitors
-
B7-H1 Antigen / metabolism*
-
CD8-Positive T-Lymphocytes / immunology*
-
Carcinoma, Squamous Cell / immunology
-
Carcinoma, Squamous Cell / therapy*
-
Clinical Trials as Topic
-
Head and Neck Neoplasms / immunology
-
Head and Neck Neoplasms / therapy*
-
Humans
-
Immunotherapy / trends*
-
Killer Cells, Natural / immunology*
-
Lymphocyte Activation
-
NK Cell Lectin-Like Receptor Subfamily C / antagonists & inhibitors
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors
-
Programmed Cell Death 1 Receptor / metabolism*
Substances
-
Antineoplastic Agents, Immunological
-
B7-H1 Antigen
-
CD274 protein, human
-
KLRC1 protein, human
-
NK Cell Lectin-Like Receptor Subfamily C
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor